Exelon and Cachexia - a phase IV clinical study of FDA data

Summary:

Cachexia is reported as a side effect among people who take Exelon (rivastigmine tartrate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Clopidogrel, and have Epilepsy.

The phase IV clinical study analyzes which people have Cachexia when taking Exelon. It is created by eHealthMe based on reports of 10,864 people who have side effects when taking Exelon from the FDA, and is updated regularly.

What is Exelon?

Exelon has active ingredients of rivastigmine tartrate. It is often used in alzheimer's disease. eHealthMe is studying from 11,060 Exelon users. Check the latest studies of Exelon.

What is Cachexia?

Cachexia (loss of weight) is found to be associated with 676 drugs and 1,199 conditions by eHealthMe. Check the latest studies of Cachexia.

On Apr, 16, 2026

10,864 people reported to have side effects when taking Exelon.
Among them, 11 people (0.1%) have Cachexia.

Among these 11 people:

How long have people been on Exelon when they have Cachexia? *

What is the gender of people who have Cachexia when taking Exelon? *

female: 80 %
male: 20 %

What is the age of people who have Cachexia when taking Exelon? *

What are other drugs people take besides Exelon? *

What are other side effects people have besides Cachexia? *

Dehydration (dryness resulting from the removal of water): 5 people, 45.45%
Drowsiness: 4 people, 36.36%
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 4 people, 36.36%
Urinary Tract Infection: 4 people, 36.36%
Fever: 4 people, 36.36%
Nausea (feeling of having an urge to vomit): 4 people, 36.36%
Nervousness: 3 people, 27.27%
Hyperhidrosis (abnormally increased sweating): 3 people, 27.27%
Fatigue (feeling of tiredness): 3 people, 27.27%
Fall: 3 people, 27.27%

What are the existing conditions these people have? *

Parkinson's Disease: 2 people, 18.18%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 18.18%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 18.18%
Stress And Anxiety: 1 person, 9.09%
Pneumonia: 1 person, 9.09%
Memory Loss: 1 person, 9.09%
Cardiac Disorder: 1 person, 9.09%
Bleeding Disorders: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Exelon and have Cachexia?

- Check whether Cachexia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Exelon:

Exelon (11,060 reports)

Cachexia treatments and more:

Cachexia (7,763 reports)

Browse all side effects of Exelon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cachexia:

Cachexia (676 drugs)

Browse all the conditions that are associated with Cachexia:

Cachexia (1,199 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rivastigmine tartrate (the active ingredients of Exelon) and Exelon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.